NL7904144A - Vetzuurpreparaten ter behandeling en voorkomen van thrombo-embolie. - Google Patents

Vetzuurpreparaten ter behandeling en voorkomen van thrombo-embolie.

Info

Publication number
NL7904144A
NL7904144A NL7904144A NL7904144A NL7904144A NL 7904144 A NL7904144 A NL 7904144A NL 7904144 A NL7904144 A NL 7904144A NL 7904144 A NL7904144 A NL 7904144A NL 7904144 A NL7904144 A NL 7904144A
Authority
NL
Netherlands
Prior art keywords
emboly
thrombo
prevention
treatment
fatty acid
Prior art date
Application number
NL7904144A
Other languages
English (en)
Other versions
NL191332C (nl
NL191332B (nl
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7904144A publication Critical patent/NL7904144A/nl
Publication of NL191332B publication Critical patent/NL191332B/nl
Application granted granted Critical
Publication of NL191332C publication Critical patent/NL191332C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL7904144A 1978-05-26 1979-05-25 Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur. NL191332C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations

Publications (3)

Publication Number Publication Date
NL7904144A true NL7904144A (nl) 1979-11-28
NL191332B NL191332B (nl) 1995-01-02
NL191332C NL191332C (nl) 1995-06-01

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904144A NL191332C (nl) 1978-05-26 1979-05-25 Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.

Country Status (13)

Country Link
JP (1) JPS5515444A (nl)
AU (1) AU527784B2 (nl)
CA (1) CA1151068A (nl)
CH (1) CH644267A5 (nl)
DE (1) DE2831507A1 (nl)
ES (1) ES8104983A1 (nl)
FR (1) FR2426461A1 (nl)
IE (1) IE48287B1 (nl)
IL (1) IL55227A (nl)
IT (1) IT1116505B (nl)
NL (1) NL191332C (nl)
NZ (1) NZ187908A (nl)
SE (1) SE448678B (nl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
MX2011011538A (es) 2009-04-29 2012-06-13 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
SI3318255T1 (sl) 2009-06-15 2021-07-30 Amarin Pharmaceuticals Ireland Limited Kompozicije in metode za zdravljenje kapi pri subjektu, ki prejema sočasno zdravljenje s statinom
CA2775339C (en) 2009-09-23 2017-03-28 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
MX2020013922A (es) 2012-06-29 2022-08-15 Amarin Pharmaceuticals Ie Ltd Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina.
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
WO2014123484A1 (en) 2013-02-06 2014-08-14 Agency For Science, Technology And Research Methods For Reducing Aggregate Content In Protein Preparations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (nl) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Also Published As

Publication number Publication date
IT1116505B (it) 1986-02-10
AU3808478A (en) 1980-01-17
CH644267A5 (en) 1984-07-31
JPS5515444A (en) 1980-02-02
FR2426461A1 (fr) 1979-12-21
NL191332C (nl) 1995-06-01
IE791023L (en) 1979-11-26
CA1151068A (en) 1983-08-02
IE48287B1 (en) 1984-11-28
DE2831507A1 (de) 1979-11-29
SE7904570L (sv) 1979-11-27
IL55227A0 (en) 1978-09-29
IL55227A (en) 1982-12-31
SE448678B (sv) 1987-03-16
ES480921A0 (es) 1981-05-16
NZ187908A (en) 1984-05-31
FR2426461B1 (nl) 1983-02-11
ES8104983A1 (es) 1981-05-16
AU527784B2 (en) 1983-03-24
DE2831507C2 (nl) 1989-07-13
NL191332B (nl) 1995-01-02
IT7947717A0 (it) 1979-01-19

Similar Documents

Publication Publication Date Title
NL7904144A (nl) Vetzuurpreparaten ter behandeling en voorkomen van thrombo-embolie.
NO821198L (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NL7613208A (nl) Werkwijze ter bereiding van plantenziekte be- strijdingsmiddelen alsmede preparaten onder toepassing hiervan.
JPS54132582A (en) Manufacture of 44pyridonee33carboxylic acid and*or its derivative
NL930039I1 (nl) Derivaten van cis endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur werkwijze voor de bereiding daarvan deze stoffen bevattende middelen en hun toepassing
NL190755C (nl) Werkwijze ter bereiding van het D-kamferaat van L-carnitinamide en het D-kamferaat van D-carnitinamide.
NL168515C (nl) Werkwijze ter bereiding van derivaten van pyrimido-Ÿ4.5-bŸ-chinolin-4(3h)-on-2-carbonzuren en werkwijze ter bereiding van deze verbindingen bevattende preparaten met anti-ulcer-werking.
NL7700425A (nl) Werkwijze voor de bereiding van preparaten en stoffen tegen maagzuur en maagzweren.
JPS54132225A (en) Skin disinfecting ointment agent and production
NL7713373A (nl) Werkwijze voor de bereiding en toepassing van propionzuurderivaten.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
NL187577C (nl) 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
JPS54144329A (en) Bissanthranilic acid derivative*its manufacture and use
NL7610378A (nl) Werkwijze voor de bereiding van 5-cyaanvaleriaanzuur en de esters daarvan.
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
TR20013A (tr) Modifiye azulmik asidler imallerine mahsus usuller ve kullanilmalari
JPS5581858A (en) Mercaptoacil derivative of pyrrolinecarboxylic acid and tetrahydropyridinecarboxylic acid
NL7506865A (nl) Werkwijze voor de bereiding van tegen allergieen werkzame preparaten en verbindingen.
NL7707202A (nl) Werkwijze voor de bereiding van isoftaalzuur en tereftaalzuur.
NL7900007A (nl) 4'-desoxy-4"arylglyoxamido- en aroylthioformamido-de- rivaten van oleandomycine en de esters daarvan.
NL7802921A (nl) Werkwijze ter bereiding van biologisch actieve preparaten.
NL180415C (nl) Esters van 2,2-dimethylcyclopropaancarbonzuur, alsmede insecticidepreparaat.
NL7805855A (nl) Farmaceutische samenstellingen en preparaten voor het behandelen van wonden.
NL7901407A (nl) Werkwijze voor de bereiding van pyrethrinen en analoga daarvan.
NL7713392A (nl) Preparaatvorm van 3-n-pyrrolidino-4-methoxy-5- -sulfamylbenzoezuur en de bereiding daarvan.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BANG EN DR. JORN DYERBERG. DR. HANS OLAF -

BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MOCHIDA PHARMACEUTICAL CO., LTD. EN NIPPON SUISAN

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990525